Home/Atriva Therapeutics/Dr. Rainer Lichtenberger
DR

Dr. Rainer Lichtenberger

Chief Executive Officer

Atriva Therapeutics

Atriva Therapeutics Pipeline

DrugIndicationPhase
Zapnometinib (ATR-002)InfluenzaPhase 2